Per Kallestrup

May Measurement Month 2017: an analysis of blood pressure screening results in Nepal-South Asia

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

DOI

  • Shiva Raj Mishra, COBIN Project, Nepal Development Society, Bharatpur-10, Narayani Zone, Chitwan, Nepal., Nepal
  • Nipun Shrestha, Institute of Health and Sport (IHES), Victoria University, Victoria 3011, Melbourne, Australia., Australia
  • Indra Prasad Poudyal, Department of Community Medicine and Public Health, Institute of Medicine, Tribhuvan University, Maharajgunj, Kathmandu, Nepal., Nepal
  • Milan Malla, Patan Academy of Health Sciences, Lalitpur, Nepal., Nepal
  • Bishal Gyawali, COBIN Project, Nepal Development Society, Bharatpur-10, Narayani Zone, Chitwan, Nepal.
  • ,
  • Aamod Dhoj Shrestha
  • Shashank Pokharel, Department of Community Medicine and Public Health, Institute of Medicine, Tribhuvan University, Maharajgunj, Kathmandu, Nepal., Nepal
  • Madan Gyawali, Department of Community Medicine and Public Health, Institute of Medicine, Tribhuvan University, Maharajgunj, Kathmandu, Nepal., Nepal
  • Surendra Sapkota, Department of Community Medicine and Public Health, Institute of Medicine, Tribhuvan University, Maharajgunj, Kathmandu, Nepal., Nepal
  • Harikrishna Bhattarai, COBIN Project, Nepal Development Society, Bharatpur-10, Narayani Zone, Chitwan, Nepal., Nepal
  • Liladhar Dhakal, COBIN Project, Nepal Development Society, Bharatpur-10, Narayani Zone, Chitwan, Nepal., Nepal
  • Pabitra Babu Soti, COBIN Project, Nepal Development Society, Bharatpur-10, Narayani Zone, Chitwan, Nepal., Nepal
  • Sagar Ghimire, Department of Health Services, Ministry of Health and Population, Kathmandu, Nepal., Nepal
  • Rajan Paudel, Department of Community Medicine and Public Health, Institute of Medicine, Tribhuvan University, Maharajgunj, Kathmandu, Nepal., Nepal
  • Xin Xia, Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK., United Kingdom
  • Thomas Beaney, Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK., United Kingdom
  • Sweta Koirala, COBIN Project, Nepal Development Society, Bharatpur-10, Narayani Zone, Chitwan, Nepal., Nepal
  • Michael Hecht Olsen, Department of Internal Medicine, Holbaek Hospital, University of Southern Denmark, 4300 Holbæk, Denmark; and., Denmark
  • Neil R Poulter, Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK., United Kingdom
  • Per Kallestrup
  • Dinesh Neupane, COBIN Project, Nepal Development Society, Bharatpur-10, Narayani Zone, Chitwan, Nepal., Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 2120, USA.

Hypertension is the leading risk factor of mortality in Nepal accounting for ∼33 000 deaths in 2016. However, more than 50% of the hypertensive patients are unaware of their status. We participated in the May Measurement Month 2017 (MMM17) project initiated worldwide by the International Society of Hypertension to raise the awareness on the importance of blood pressure (BP) screening. In this paper, we discuss the screening results of MMM17 in Nepal. An opportunistic cross-sectional survey of volunteers aged ≥18 years was carried out in May 2017 following the standard MMM protocol. Data were collected from 18 screening sites in 7 districts covering 5 provinces. Screenings were conducted either in health facilities, public places, or participants' homes. Trained volunteers with health science background and female community health volunteers were mobilized to take part in the screening. A total of 5972 individuals were screened and of 5968 participants, for whom a mean of the 2nd and 3rd readings was available, 1456 (24.4%) participants had hypertension; 908 (16.8%) of those not receiving treatment were hypertensive; and 248 (45.2%) of those being treated had uncontrolled BP. MMM17 is the first nationwide BP screening campaign undertaken in Nepal. Given the suboptimal treatment and control rates identified in the study, there is a strong imperative to scale up hypertension prevention, screening, and management programmes. These results suggest that opportunistic screening can identify significant numbers with hypertension. Mobilization of existing volunteer networks and support of community stakeholders, would be necessary to improve the overall impact and sustainability of future screening programmes.

Original languageEnglish
JournalEuropean Heart Journal Supplements
Volume21
IssueSuppl D
Pages (from-to)D83-D85
Number of pages3
ISSN1554-2815
DOIs
Publication statusPublished - Apr 2019

See relations at Aarhus University Citationformats

ID: 152236966